Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells

Qunfang Li1, Sharlin Ahmed, Jeffrey A Loeb

  • 1Department of Neurology and Center for Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan 48201, USA.

Cancer Research
|October 7, 2004
PubMed

Insights

Neuregulin (NRG) signaling shifts from inhibiting to promoting breast cancer cell proliferation as cells become malignant. Disrupting this NRG autocrine loop may offer a new breast cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Neuregulin (NRG) is a growth factor that activates epidermal growth factor receptors, including erbB2, which is often overexpressed in aggressive breast cancer.
  • NRG's role in breast cancer is complex, exhibiting both proliferative and antiproliferative effects depending on the cell line.
  • Understanding NRG's function is crucial for developing targeted breast cancer therapies.

Purpose of the Study:

  • To investigate the changing role of Neuregulin (NRG) signaling in breast epithelial cells during malignant progression.
  • To identify the molecular mechanisms underlying the switch from antiproliferative to proliferative effects of NRG.
  • To explore the therapeutic potential of disrupting NRG signaling in breast cancer.

Main Methods:

  • Utilized an isogenic series of MCF10A breast epithelial cell lines representing benign to malignant stages.
  • Analyzed gene expression changes using cDNA microarrays.
  • Assessed erbB receptor expression, NRG secretion, and receptor phosphorylation levels.
  • Investigated the effect of blocking ligand-induced receptor activation on cancer cell proliferation.

Main Results:

  • NRG's effect shifted from antiproliferative to proliferative as MCF10A cells progressed towards malignancy.
  • Malignant cells showed increased erbB2, decreased erbB3, and high NRG secretion, leading to constitutive erbB receptor phosphorylation.
  • NRG signaling formed an autocrine loop that promoted cancer cell proliferation.
  • Inhibiting this autocrine loop by blocking receptor activation suppressed cancer cell growth.

Conclusions:

  • The progression of breast epithelial cells to malignancy is associated with the development of a constitutively active, pro-proliferative NRG autocrine signaling loop.
  • This autocrine loop is driven by altered erbB receptor expression and high NRG secretion.
  • Disrupting this NRG autocrine signaling loop represents a potential therapeutic strategy for controlling breast cancer growth.

Related Concept Videos

Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...